SMT — Sahajanand Medical Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹38.39bn
- IN₹40.91bn
- IN₹12.10bn
Annual cashflow statement for Sahajanand Medical Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -304 | 313 | 331 | 408 | 803 |
| Depreciation | |||||
| Non-Cash Items | 732 | 496 | 351 | 357 | 137 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -638 | -898 | -916 | -655 | -629 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 168 | 459 | 411 | 735 | 1,052 |
| Capital Expenditures | -953 | -236 | -423 | -490 | -980 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -594 | 1,196 | -1.94 | 0.6 | -320 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,547 | 960 | -425 | -489 | -1,300 |
| Financing Cash Flow Items | -150 | -306 | -169 | -328 | -367 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,089 | -1,723 | 131 | 57.7 | -120 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -287 | -295 | 124 | 289 | -264 |